Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0N6QU
|
||||
| Former ID |
DNC009467
|
||||
| Drug Name |
2-hydroxygarveatin E
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [528499] | ||
| Formula |
C20H20O6
|
||||
| Canonical SMILES |
CCC1=C(C(=O)C2=CC3=C(C(=C2C1=O)O)C(=O)C(C(=O)C3(C)C)(C)<br />O)C
|
||||
| InChI |
1S/C20H20O6/c1-6-9-8(2)14(21)10-7-11-13(16(23)12(10)15(9)22)17(24)20(5,26)18(25)19(11,3)4/h7,23,26H,6H2,1-5H3
|
||||
| InChIKey |
MEDXQZJJCUKMBX-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Indoleamine 2,3-dioxygenase | Target Info | Inhibitor | [528499] | |
| PathWhiz Pathway | Tryptophan Metabolism | ||||
| Reactome | Tryptophan catabolism | ||||
| References | |||||